Clinical Trial Update: Bioequivalence Study of Temozolomide in Patients With Primary Tumors of the Central Nervous System [Phase 4]

View source ↗

Summary

Phase 4 bioequivalence study of temozolomide in patients with primary malignant brain tumors has been completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Neoplasms
• Malignant Brain Neoplasms

Drugs mentioned

• Temodar (Temozolomide)

Snippet

Sponsor: Monte Verde SA | Conditions: Brain Neoplasms, Malignant, Primary | Phase 4 | Status: COMPLETED | Results posted: 2015-04-02